Management of Periprosthetic Joint Infection in Total Elbow Arthroplasty

Authors/contributors
Abstract
Periprosthetic joint infection (PJI) is a potentially devastating complication after total elbow arthroplasty (TEA) that can lead to significant morbidity for the patient as well as increased health care–related costs. Despite the potential morbidity associated with TEA PJI, evidence is limited regarding an optimal treatment algorithm. Initial management typically consists of either irrigation and debridement or 2-stage revision. A stable implant, a functioning triceps, and an intact soft tissue envelope are necessary to perform irrigation and debridement. Irrigation and debridement is associated with a relatively high risk of infection recurrence especially in chronic infections. Two-stage revision offers a lower recurrence risk, although there is a 25% chance of not completing the second stage. Resection arthroplasty, arthrodesis, and amputation are salvage options, whereas medical treatment, in the form of antibiotics alone, is reserved for poor surgical candidates. Further multicenter prospective study and retrospective review of registry data focusing on different treatment algorithms, prevention strategies, and functional outcomes would be helpful to elucidate the ideal management of elbow PJI.
Publication
Journal of Hand Surgery
Date
2020-10-01
Extra
Publisher: Elsevier PMID: 32753227
Citation
1.
Goyal N, Luchetti TJ, Wysocki RW, Cohen MS. Management of Periprosthetic Joint Infection in Total Elbow Arthroplasty. Journal of Hand Surgery. 2020;45(10):957-970.